Pharma and biotech companies routinely seek the opinion of leading academics and researchers, but interviewing thought leaders (more commonly known as Key Opinion Leaders or KOLs) is an art, rather than a science.
Tag Archives | breast cancer market research
It was interesting to note that Tomasz Borkowski (Department of Urology at the Medical University of Warsaw) who gave a major session presentation at EAU on “Cancer induced bone disease – prevention and treatment’ listed only one company on his disclosures. Clearly, some companies are ahead of others in identifying and building relationships with thought […]
One of the pharma marketing strategy consulting services that we offer clients is a competitive landscape, market opportunity report. These custom reports analyze a pathway, disease, tumor type or competitive set, and can include a thorough analysis of clinical data, biomarkers, epidemiology, market size and competitor activity. All our work comes with actionable insights and […]
Sally Church on Pharma Strategy Blog discusses the issue of to what extent hormone replacement therapy (HRT) is linked to a higher incidence of breast cancer?
Nanotechnology is expected to provide major breakthroughs in how drugs cross the blood-brain barrier and reach into tumors. That promise is already starting to be seen. Research by Julia Ljubimova and her team at Cedars-Sinai Medical Center was recently published in the AACR journal, Cancer Research. They showed that biodegradable nanoparticles containing trastuzumab (herceptin), dramatically […]